Tun R Y, Smith M D, Lo S S, Rook G A, Lydyard P, Leslie R D
Department of Diabetes and Metabolism, St. Bartholomew's Hospital, London, UK.
Diabet Med. 1994 Jan-Feb;11(1):66-70. doi: 10.1111/j.1464-5491.1994.tb00232.x.
To determine whether antibodies to mycobacterial heat shock protein of 65 kD molecular weight (hsp 65) could be important in the pathogenesis of Type 1 diabetes we tested patients before and at diagnosis of diabetes, as well as patients with rheumatoid arthritis. Using ELISA, increased hsp 65 antibodies were detected in 2 of 8 pre-diabetic twins, 1 of 13 newly diagnosed untreated diabetic patients and 3 of 10 rheumatoid arthritis patients. Levels of hsp 65 antibodies in pre-diabetic twins, median (range), 0.25 (0.104-1.904) and newly diagnosed diabetic patients (mean +/- SD) (0.299 +/- 0.220), did not differ significantly either from each other or from their control subjects (0.134 +/- 0.123). In contrast, levels of hsp 65 antibodies in rheumatoid patients (0.59 +/- 0.42) were significantly higher than in their control subjects (0.21 +/- 0.18; p = 0.02). Of twins studied prospectively before diagnosis, at diagnosis but before insulin treatment, and soon after diagnosis, three of four had hsp 65 antibodies at some stage. We conclude that serological immunity to mycobacterial hsp 65 can occur in Type 1 diabetes, but it is neither a characteristic nor a specific feature of the disease.
为了确定分子量为65kD的分枝杆菌热休克蛋白(hsp 65)抗体在1型糖尿病发病机制中是否起重要作用,我们对糖尿病患者诊断前、诊断时以及类风湿关节炎患者进行了检测。采用酶联免疫吸附测定法(ELISA),在8例糖尿病前期双胞胎中的2例、13例新诊断未治疗的糖尿病患者中的1例以及10例类风湿关节炎患者中的3例检测到hsp 65抗体水平升高。糖尿病前期双胞胎中hsp 65抗体水平的中位数(范围)为0.25(0.104 - 1.904),新诊断糖尿病患者的水平(均值±标准差)为(0.299±0.220),二者之间以及与各自的对照受试者(0.134±0.123)相比均无显著差异。相比之下,类风湿患者中hsp 65抗体水平(0.59±0.42)显著高于其对照受试者(0.21±0.18;p = 0.02)。在诊断前、诊断时但未进行胰岛素治疗以及诊断后不久对双胞胎进行前瞻性研究,4例中有3例在某个阶段出现hsp 65抗体。我们得出结论,1型糖尿病患者可出现针对分枝杆菌hsp 65的血清免疫,但这既不是该疾病的特征性表现也不是特异性特征。